NASDAQ:ABVC

Abvc Biopharma Stock Insider Trading

etoro logo Buy ABVC
*Your capital is at risk
$1.28
+0.0300 (+2.40%)
At Close: Jun 03, 2026

ABVC BioPharma Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 48.54M and sold 8.7M ABVC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
0
Buy 48.54M shares
Sell 8.7M shares
94% Buy Activity
Negligible or No Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Sep 21, 2009
Buy
Common Stock
A-Award
Krotine Frank Thomas
President & COO
CEO / President 169 000
Value: $86.2K
Sep 21, 2009
Buy
Common Stock
A-Award
Crockett Robert G
Chief Executive Officer
CEO / President 670 000
Value: $341.7K
Sep 21, 2009
Buy
Common Stock
A-Award
Iannotti Daniel V
Vp, General Counsel & Secretar
Officer 70 000
Value: $35.7K
Sep 21, 2009
Buy
Common Stock
A-Award
Krotine Frank Thomas
President & COO
CEO / President 169 000
Value: $86.2K
Sep 21, 2009
Buy
Common Stock
A-Award
Crockett Robert G
Chief Executive Officer
CEO / President 670 000
Value: $341.7K
Sep 14, 2009
Sell
Common Stock
J-Other
Smith J.b.
Director 50 000
Value: $100.0K
Sep 14, 2009
Sell
Common Stock
J-Other
Smith J.b.
Director 50 000
Value: $100.0K
Aug 31, 2009
Buy
Common Stock
P-Purchase
Smith J.b.
Director 192 308
Value: $9.62B
Aug 31, 2009
Buy
Common Stock
P-Purchase
Smith J.b.
Director 192 308
Value: $9.62B
Aug 31, 2009
Buy
Common Stock
P-Purchase
Smith J.b.
Director 192 308
Value: $9.62B
Aug 31, 2009
Buy
Common Stock
P-Purchase
Smith J.b.
Director 192 308
Value: $9.62B
Aug 19, 2009
Sell
Common Stock
G-Gift
Smith J.b.
Director 300 000
Value: $0
Aug 19, 2009
Sell
Common Stock
G-Gift
Smith J.b.
Director 300 000
Value: $0
Aug 11, 2009
Buy
Options to acquire common stock
Iannotti Daniel V
Vp, General Counsel & Secretar
Officer 220 000
Value: $112.2K
Aug 11, 2009
Buy
Options to acquire common stock
Iannotti Daniel V
Vp, General Counsel & Secretar
Officer 220 000
Value: $112.2K
Jan 23, 2009
Sell
Common Stock
S-Sale
Stromback Richard Dean
Director 4 000 000
Value: $4.00M
Jan 23, 2009
Sell
Common Stock
S-Sale
Stromback Richard Dean
Director 4 000 000
Value: $4.00M
Oct 20, 2008
Buy
Options to acquire common stock
A-Award
Nirta Joseph
Director
Director 100 000
Value: $104.0K
Oct 20, 2008
Buy
Options to acquire common stock
A-Award
Nirta Joseph
Director
Director 100 000
Value: $104.0K
Jul 28, 2008
Buy
Warrants
Juliano James
Director
Director 1 178 500
Value: $883.9K
Jul 28, 2008
Buy
Warrants
Juliano James
Director
Director 1 178 500
Value: $883.9K
Jun 26, 2007
Buy
Stock Options
Juliano James
Director
Director 500 000
Value: $450.0K
Jun 26, 2007
Buy
Stock Options
Juliano James
Director
Director 500 000
Value: $450.0K
Mar 01, 2007
Buy
Options to acquire Common Stock
P-Purchase
Stromback Richard Dean
Director 10 000
Value: $20.0K
Mar 01, 2007
Buy
Options to acquire Common Stock
P-Purchase
Stromback Richard Dean
Director 10 000
Value: $20.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ABVC BIOPHARMA, INC.
ABVC BioPharma
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity d...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE